 We present tocilizumab desensitization of a 47-year-old woman affected by rheumatoid arthritis<disease><symptom> with full body delayed erythematous urticarial reaction. Skin test for tocilizumab gave cutaneous reaction after 6 h at 20 mg/mL. The schedule of desensitization was then adapted for non-immediate reaction. We prepared a desensitization procedure reaching the cumulative dose of 516 mg in 5 weeks. After 6 months , the repetition of skin tests had a negative result , with demonstration of tolerance induction. Today the patient has good control of the disease.